NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Ref # 300900 (marketed under EUA202947). Dist...

FDA Device Recall #Z-0738-2022 — Class II — January 21, 2022

Recall Summary

Recall Number Z-0738-2022
Classification Class II — Moderate risk
Date Initiated January 21, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm NeuMoDx Molecular Inc
Location Ann Arbor, MI
Product Type Devices
Quantity 102 boxes

Product Description

NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Ref # 300900 (marketed under EUA202947). Distributed in boxes of 6 assay strips in individual pouches. Box, pouch and strips all labeled with product name, ref #, lot #, and expiration date.

Reason for Recall

A risk for product contamination was identified for the affected product lot. If used, there is an increased potential for SARS-CoV-2 false positive results when using the product.

Distribution Pattern

US Nationwide distribution in the states of FL, MD, MI, NY.

Lot / Code Information

Lot: 116305 S/L-02 (Sublot 02),UDI: 10814278020830

Other Recalls from NeuMoDx Molecular Inc

Recall # Classification Product Date
Z-2255-2023 Class II NeuMoDx Cartridge-used for extraction, purifica... May 24, 2023
Z-2093-2023 Class III NeuMoDx SARS-CoV-2 Assay -IVD intended for the... May 15, 2023
Z-1251-2022 Class II NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Str... May 13, 2022
Z-1000-2022 Class II NeuMoDx Cartridge-For in vitro diagnostic use w... Feb 18, 2022
Z-1978-2021 Class II NeuMoDx Cartridge, For In Vitro Diagnostic Use ... May 4, 2021

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.